Batch Testing ‘Could Double’ Under Govt Proposals For Great Britain
Executive Summary
The UK government is consulting on a set of options for batch testing of imported medicines as it seeks to balance patient safety principles with the need to avoid overly burdensome import requirements.
You may also be interested in...
Industry Breathes Sigh Of Relief Over UK Batch Release Move
One of the key regulatory conundrums thrown up by Brexit has been addressed after the government decided to continue using a list of approved countries to waive drug import testing requirements.
Industry Breathes Sigh Of Relief Over UK Batch Release Move
One of the key regulatory conundrums thrown up by Brexit has been addressed after the government decided to continue using a list of approved countries to waive drug import testing requirements.
UK’s Rising Rebate Threatens Branded Generic And Biosimilar Supply
Warnings over a rising UK rebate that applies to branded generics and biosimilars have gained renewed urgency after some firms indicated plans to cut supply or withdraw from the market altogether, according to local off-patent industry association the BGMA.